articleTop 10% cited
Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function.
Journal of Pharmacology and Experimental Therapeutics · 1996 · Vol. 279(3) · pp. 1453–1461
Cytokine Signaling Pathways and InteractionsSynthesis and biological activityInflammatory mediators and NSAID effectsCytokineArthritisPharmacologyMedicineBone resorptionImmune systemTumor necrosis factor alphaIn vivoOvalbuminEx vivo
MeSH terms
AnimalsArthritisBone ResorptionCollagenDisease Models, AnimalEnzyme InhibitorsFemaleImidazolesMaleMice, Inbred StrainsPyridinesRats, Inbred LewShock, SepticTumor Necrosis Factor-alphaArachidonic Acid
Citations
499
FWCI
12.21
field-weighted impact
References
0
Percentile
99%
vs. same field & year
Citations per year
Cited by
The role of protein phosphorylation in human health and disease.
European Journal of Biochemistry · 2001 · 650 citations
Specificity and mechanism of action of some commonly used protein kinase inhibitors
Biochemical Journal · 2000 · 4,060 citations
Neutrophils and acute lung injury
Critical Care Medicine · 2003 · 849 citations
Imidazopyrimidines, potent inhibitors of p38 MAP kinase
Bioorganic & Medicinal Chemistry Letters · 2003 · 250 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.